A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 192 participants.

Also called NCT02072096

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02072096
  • EudraCT 2013-001473-24
Other papers using this trial's data
  • Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM) Diabetes, obesity & metabolism, 2018-01 DOI, PubMed 28671753, PMC5724506 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Germany, Puerto Rico, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02072096. Randomized; no masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-10 (actual). Results posted on 2016-11-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Acronym
IMPERIUM
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Glimepiride
Intervention (Drug)
Metformin
Intervention (Drug)
Pioglitazone
Intervention (Drug)
Acarbose
Intervention (Drug)
Linagliptin
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Liraglutide
Intervention (Drug)
Insulin Glargine
Intervention (Drug)
Exenatide once weekly (QW)
Intervention (Drug)
Exenatide twice daily (BID)
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct02072096
Content hash
a79cc58b4d3eb3c63997f2e0c62cc32d99144833bc5baab555195b8590ff39ef